Related Experiment Videos

Status of adjuvant therapy for colorectal cancer

R J Mayer¹, M J O'Connell, J E Tepper

¹Dana-Farber Cancer Institute, Boston, MA 02115.

Journal of the National Cancer Institute

|September 20, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis.

ESMO open·2025

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).

Breast cancer research : BCR·2025

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

See all related articles